News Release 

Treatment of opioid use disorder among commercially insured patients in context of COVID-19 pandemic


Research News

What The Study Did: Opioid use disorder treatment during the early months of the COVID-19 pandemic, including medication fills, outpatient visits and urine tests among privately insured individuals, was compared with 2019 in this study.

Authors: Haiden A. Huskamp, Ph.D., of Harvard Medical School in Boston, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link


Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.